Injective Veyra upgrade vote draws 62% approval: Will INJ extend gains amid strong participation?
Injective (INJ) is trading at $8.26 after climbing 10.68% intraday. The price remains above its key moving averages, indicating firm buying interest and robust momentum to the upside.
Highlights
- Injective is holding a governance vote on the Veyra mainnet upgrade, aiming to add real-world asset infrastructure and enhanced trading protocols.
- As of November 13, 2026, 62% of votes supported the proposal with 13.97 million INJ staked, though turnout is below the 33.4% quorum.
- INJ/USD trades at $8.26 after a 10.68% daily jump, with strong upward momentum but overbought signals and an expected range of $7.87 to $8.53.
Governance vote participation and upgrade prospects drive demand
Injective has initiated a governance vote for its major Veyra mainnet upgrade, with the proposal (IIP-717) set to introduce institutional-grade real-world asset infrastructure, enhanced cross-chain interoperability, a request-for-quote trading system, and atomic swaps. As of November 13, 2026, 62% of votes were in favor and approximately 13.97 million INJ had been staked, but total turnout remained below the required 33.4% quorum, according to Kucoin. This wave of community participation and the prospect of substantial technical enhancements appear to be fueling demand for INJ, supporting the asset’s current upside momentum.
Overbought momentum as INJ tests strong resistance and support
INJ/USD is above its MA-20 at $7.46, MA-50 at $7.57, and well above the MA-200 at $5.77, while the Ichimoku Kijun sits at $7.48 and offers immediate support. Resistance is seen near $8.53, with support at $7.87 and $7.48. Momentum readings are mixed: RSI is neutral, while both Stochastic RSI and CCI are overbought, highlighting overheating risk. MACD and ADX remain neutral, Bull/Bear Power at 0.28 signals modest buyer strength intraday, and the Awesome Oscillator aligns with the upward movement. Intraday volatility is elevated, with no gap from the previous close, confirming strong upward pressure amid some caution from oscillators.
Consolidation expected as volatility cools after sharp rally
In the short term, INJ is likely to consolidate within the $7.87–$8.53 range as volatility stabilizes following the latest surge. With upside probability very high, a breakout above $8.53 could open the door for further gains. Conversely, a drop below immediate support at $7.48 would indicate risk of a deeper retracement, but this scenario currently appears unlikely barring a shift in participation or sentiment.
Earlier, analysts noted that Injective's growth potential hinged on accelerating adoption of its institutional-grade infrastructure and increasing protocol revenue amid an evolving regulatory and competitive landscape. The current initiative to upgrade via the Veyra mainnet vote—coupled with persistent technical strength—adds a significant catalyst, making the upcoming quorum threshold a crucial pivot point for traders monitoring breakout risk above established resistance.